AbbVie, Inc. (ABBV)
291.31
+3.07
(+1.07%)
USD |
NYSE |
Nov 06, 16:00
291.30
-0.01
(0.00%)
After-Hours: 20:00
AbbVie EPS Diluted (TTM) : 5.810 for Sept. 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.810 |
| June 30, 2026 | 3.537 |
| March 31, 2026 | 2.027 |
| December 31, 2025 | 2.361 |
| September 30, 2025 | 1.325 |
| June 30, 2025 | 2.101 |
| March 31, 2025 | 2.345 |
| December 31, 2024 | 2.392 |
| September 30, 2024 | 2.867 |
| June 30, 2024 | 2.990 |
| March 31, 2024 | 3.358 |
| December 31, 2023 | 2.720 |
| September 30, 2023 | 3.654 |
| June 30, 2023 | 4.869 |
| March 31, 2023 | 4.247 |
| December 31, 2022 | 6.631 |
| September 30, 2022 | 7.503 |
| June 30, 2022 | 7.067 |
| March 31, 2022 | 6.974 |
| December 31, 2021 | 6.450 |
| September 30, 2021 | 4.198 |
| June 30, 2021 | 3.713 |
| March 31, 2021 | 2.832 |
| December 31, 2020 | 2.863 |
| September 30, 2020 | 4.729 |
| Date | Value |
|---|---|
| June 30, 2020 | 4.701 |
| March 31, 2020 | 5.650 |
| December 31, 2019 | 5.281 |
| September 30, 2019 | 2.174 |
| June 30, 2019 | 2.72 |
| March 31, 2019 | 3.49 |
| December 31, 2018 | 3.58 |
| September 30, 2018 | 4.84 |
| June 30, 2018 | 4.04 |
| March 31, 2018 | 3.97 |
| December 31, 2017 | 3.29 |
| September 30, 2017 | 4.11 |
| June 30, 2017 | 4.07 |
| March 31, 2017 | 3.86 |
| December 31, 2016 | 3.63 |
| September 30, 2016 | 3.70 |
| June 30, 2016 | 3.47 |
| March 31, 2016 | 3.32 |
| December 31, 2015 | 3.12 |
| September 30, 2015 | 1.69 |
| June 30, 2015 | 1.26 |
| March 31, 2015 | 1.11 |
| December 31, 2014 | 1.09 |
| September 30, 2014 | 2.30 |
| June 30, 2014 | 2.59 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Biogen, Inc. | 2.336 |
| Gilead Sciences, Inc. | -3.149 |
| Regeneron Pharmaceuticals, Inc. | 45.30 |
| Amgen, Inc. | 17.24 |
| REGENXBIO, Inc. | -3.785 |